225 related articles for article (PubMed ID: 28782577)
21. Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer.
Bayarmaa B; Wu Z; Peng J; Wang Y; Xu S; Yan T; Yin W; Lu J; Zhou L
BMC Cancer; 2019 Sep; 19(1):877. PubMed ID: 31488093
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of PAX6 by promoter methylation is associated with poor prognosis in non small cell lung cancer.
Zhang X; Yang X; Wang J; Liang T; Gu Y; Yang D
Int J Clin Exp Pathol; 2015; 8(9):11452-7. PubMed ID: 26617874
[TBL] [Abstract][Full Text] [Related]
23. LncRNA MEG3 acts a biomarker and regulates cell functions by targeting ADAR1 in colorectal cancer.
Wang W; Xie Y; Chen F; Liu X; Zhong LL; Wang HQ; Li QC
World J Gastroenterol; 2019 Aug; 25(29):3972-3984. PubMed ID: 31413531
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC.
Liu L; Qu W; Zhong Z
Int J Clin Exp Pathol; 2015; 8(5):5609-13. PubMed ID: 26191272
[TBL] [Abstract][Full Text] [Related]
25. Decreased expression of MEG3 contributes to retinoblastoma progression and affects retinoblastoma cell growth by regulating the activity of Wnt/β-catenin pathway.
Gao Y; Lu X
Tumour Biol; 2016 Feb; 37(2):1461-9. PubMed ID: 26662307
[TBL] [Abstract][Full Text] [Related]
26. Bioinformatics analysis of LINC00426 expression in lung cancer and its correlation with patients' prognosis.
Du W; Sun J; Gu J; Zhang S; Zhang T
Thorac Cancer; 2020 Jan; 11(1):150-155. PubMed ID: 31691516
[TBL] [Abstract][Full Text] [Related]
27. Prognostic impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non-small-cell lung cancer.
Schmidt LH; Görlich D; Spieker T; Rohde C; Schuler M; Mohr M; Humberg J; Sauer T; Thoenissen NH; Huge A; Voss R; Marra A; Faldum A; Müller-Tidow C; Berdel WE; Wiewrodt R
J Thorac Oncol; 2014 Sep; 9(9):1294-304. PubMed ID: 25036876
[TBL] [Abstract][Full Text] [Related]
28. Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.
Zhou M; Zhao H; Wang Z; Cheng L; Yang L; Shi H; Yang H; Sun J
J Exp Clin Cancer Res; 2015 Sep; 34(1):102. PubMed ID: 26362431
[TBL] [Abstract][Full Text] [Related]
29. Characterization of long non-coding RNA expression profiles in lymph node metastasis of early-stage cervical cancer.
Shang C; Zhu W; Liu T; Wang W; Huang G; Huang J; Zhao P; Zhao Y; Yao S
Oncol Rep; 2016 Jun; 35(6):3185-97. PubMed ID: 27035672
[TBL] [Abstract][Full Text] [Related]
30. Analysis of lncRNA expression profiles in non-small cell lung cancers (NSCLC) and their clinical subtypes.
Yang J; Lin J; Liu T; Chen T; Pan S; Huang W; Li S
Lung Cancer; 2014 Aug; 85(2):110-5. PubMed ID: 24906504
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA HNF1A-AS1 up-regulation in non-small cell lung cancer correlates to poor survival.
Ma YF; Liang T; Li CR; Li YJ; Jin S; Liu Y
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(23):4858-4863. PubMed ID: 27981551
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
33. A three gene-based risk score predicts prognosis of resected non-small-cell lung cancer.
Liu K; Chen HL; Gu MM; You QS
Int J Clin Exp Pathol; 2015; 8(12):16081-8. PubMed ID: 26884885
[TBL] [Abstract][Full Text] [Related]
34. Identification of circulating long non-coding RNA GAS5 as a potential biomarker for non-small cell lung cancer diagnosisnon-small cell lung cancer, long non-coding RNA, plasma, GAS5, biomarker.
Tan Q; Zuo J; Qiu S; Yu Y; Zhou H; Li N; Wang H; Liang C; Yu M; Tu J
Int J Oncol; 2017 May; 50(5):1729-1738. PubMed ID: 28339045
[TBL] [Abstract][Full Text] [Related]
35. High lncRNA H19 expression as prognostic indicator: data mining in female cancers and polling analysis in non-female cancers.
Peng L; Yuan XQ; Liu ZY; Li WL; Zhang CY; Zhang YQ; Pan X; Chen J; Li YH; Li GC
Oncotarget; 2017 Jan; 8(1):1655-1667. PubMed ID: 27926484
[TBL] [Abstract][Full Text] [Related]
36. An eight-long non-coding RNA signature as a candidate prognostic biomarker for lung cancer.
Tu Z; He D; Deng X; Xiong M; Huang X; Li X; Hao L; Ding Q; Zhang Q
Oncol Rep; 2016 Jul; 36(1):215-22. PubMed ID: 27222340
[TBL] [Abstract][Full Text] [Related]
37. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
[TBL] [Abstract][Full Text] [Related]
38. Combined eight-long noncoding RNA signature: a new risk score predicting prognosis in elderly non-small cell lung cancer patients.
Miao R; Ge C; Zhang X; He Y; Ma X; Xiang X; Gu J; Fu Y; Qu K; Liu C; Wu Q; Lin T
Aging (Albany NY); 2019 Jan; 11(2):467-479. PubMed ID: 30659574
[TBL] [Abstract][Full Text] [Related]
39. RNA-Seq analysis of non-small cell lung cancer in female never-smokers reveals candidate cancer-associated long non-coding RNAs.
Li J; Bi L; Shi Z; Sun Y; Lin Y; Shao H; Zhu Z
Pathol Res Pract; 2016 Jun; 212(6):549-54. PubMed ID: 27067812
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA MEG3 as a candidate prognostic factor for induction therapy response and survival profile in childhood acute lymphoblastic leukemia patients.
Gao W
Scand J Clin Lab Invest; 2021 May; 81(3):194-200. PubMed ID: 33600264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
